Abstract:introduction This study was designed to investigate the effects of Saffron supplementation on liver FibroScan test, liver enzymes, lipid profile, total and direct bilirubin, glycemic profile, and blood pressure in nonalcoholic fatty liver disease (NAFLD) patients. The researchers hypothesized that supplementation with Saffron could further improve the efficacy of lifestyle modifications in managing NAFLD. Methods This randomized, double-blind, placebo-controlled trial was conducted on 76 NAFLD patients, whose age range was from 18 to 65. All of them were given a specified weight loss diet and a physical activity program. They were randomly assigned into two groups to intake 100 mg of a Saffron-coated tablet (n=38) or a placebo tablet (n=38) for 12 weeks. Liver FibroScan test, liver enzymes (as primary outcome), lipid profile, total and direct bilirubin, fasting blood sugar (FBS), insulin, insulin resistance (HOMA-IR), insulin sensitivity (QUICKI), blood pressure, dietary intake, and physical activity were measured at baseline and also after 12 weeks. Both the participants and the dietitians were blindly assigned to the groups. Statistical analysis was carried out using SPSS software version 22. Results Finally, 36 patients completed the study, and 38 patients were included in the intention-to-treat analysis. Accordingly, Saffron supplementation reduced steatosis score (P > 0.001), steatosis percent (P > 0.001) and steatosis stage (P > 0.001), total cholesterol (TC) (P = 0.001), triacylglycerol (TG) (P > 0.001), LDL-C (P = 0.005), and FBS (P = 0.009) more than placebo. There was no significant difference in liver fibrosis, ALT (-1.33 IU/L, 95% CI= -5.10, 2.43, P = 0.482), AST (-0.20 IU/L, 95% CI= -2.94, 2.52, P = 0.880), GGT, insulin, HOMA-IR, and QUICKI indexes, total and direct bilirubin, and blood pressure between the two groups (P > 0.05). Conclusions Overall, the 12-week consumption of 100 mg Saffron, along with lifestyle modification, compared with placebo, had insignificant reducing effects on liver steatosis score, steatosis percent, and steatosis stage, total cholesterol, TG, LDL-C, and FBS among NAFLD patients. Saffron may exert considerable beneficial consequences that need further assessment in future clinical trials.

Effect of Crocin From Saffron (Crocus sativus L.) Supplementation on Oxidant/Antioxidant Markers, Exercise Capacity, and Pulmonary Function Tests in COPD Patients: A Randomized, Double-Blind, Placebo-Controlled Trial

Crocin Supplementation on Inflammation and Oxidative Stress: A Systematic Review and Meta‐Analysis

Effects of Crocin on Inflammatory Biomarkers and Mental Health Status in Patients with Multiple Sclerosis: A Randomized, Double-Blinded Clinical Trial

Effects of crocin and saffron aqueous extract on gene expression of SIRT1, AMPK, LOX1, NF‐κB, and MCP‐1 in patients with coronary artery disease: A randomized placebo‐controlled clinical trial

The effect of different treatment modalities on oxidative stress in COPD

The suppressive effects of crocin from saffron on allergic airway inflammation through Drp1/Nfr1/Mfn2/Pgc1-alpha signaling pathway in mice

The effect of crocin on movement disorders and oxidative DNA damage in Parkinson's disease: Insights from a randomized controlled trial

Therapeutic effects of black seed oil supplementation on chronic obstructive pulmonary disease patients: A randomized controlled double blind clinical trial

Nanocurcumin supplementation improves pulmonary function in severe COPD patients: A randomized, double blind, and placebo‐controlled clinical trial

The effects of saffron (Crocus sativus L.) in conjunction with concurrent training on body composition, glycaemic status, and inflammatory markers in obese men with type 2 diabetes mellitus: A randomized double-blind clinical trial

Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Concurrent Use of Crocin During Chemoradiation for Esophageal Squamous Cell Carcinoma

Antidiabetic and antioxidant potential of Crocin in high-fat diet plus streptozotocin-induced type-2 diabetic rats

Adjunctive Treatment with Rhodiola Crenulata in Patients with Chronic Obstructive Pulmonary Disease – A Randomized Placebo Controlled Double Blind Clinical Trial

Effect of Crocus sativus Extract Supplementation in the Metabolic Control of People with Diabetes Mellitus Type 1: A Double-Blind Randomized Placebo-Controlled Trial

The Effects of Saffron ( Crocus Sativus L ) Supplementation on Cardiovascular Risk Factors, Liver Steatosis and Fibrosis in Patients with Nonalcoholic Fatty Liver Disease: A Randomized, Double-blind, Placebo-controlled Study

Crocin averts functional and structural rat hepatic disturbances induced by copper oxide nanoparticles

Functional Mechanisms of Dietary Crocin Protection in Cardiovascular Models under Oxidative Stress

An evaluation of the effects of saffron supplementation on the asthma clinical symptoms and asthma severity in patients with mild and moderate persistent allergic asthma: a double-blind, randomized placebo-controlled trial

Comparative assessment of immunomodulatory, proliferative, and antioxidant activities of crocin and crocetin on mesenchymal stem cells

Compound glycyrrhiza oral solution alleviates oxidative stress and inflammation by regulating SRC/MAPK pathway in chronic obstructive pulmonary disease

Effect of nano-curcumin supplementation on cardiometabolic risk factors, physical and psychological quality of life, and depression in patients with coronary slow flow phenomenon: a randomized double-blind clinical trial